In the BioHarmony Drug Report Database

"Preview" Icon

Mecasermin rinfabate

Iplex, Increlex (mecasermin rinfabate) is a protein pharmaceutical. Mecasermin rinfabate was first approved as Iplex on 2005-12-12. It has been approved in Europe to treat laron syndrome.

 

Trade Name

 

Increlex
 

Common Name

 

mecasermin rinfabate
 

ChEMBL ID

 

CHEMBL1201717
 

Indication

 

laron syndrome
 

Drug Class

 

Growth factors: insulin-like growth factors

Image (chem structure or protein)

Mecasermin rinfabate structure rendering